Storage Condition
Refer MSDS for complete information
Synonyms
(S)-4-(2-((1-(2-Aminophenyl)-3-methylbutyl)amino)-2-oxoethyl)-2-(ethoxy-d5)benzoic Acid
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Repaglinide M1-d5 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Repaglinide M1-d5 usage and description
Repaglinide M1-D5 is a metabolite of Repaglinide, a medication used to treat type 2 diabetes. This metabolite is formed when Repaglinide is metabolized by the liver. Repaglinide M1-D5 is an active metabolite and has similar pharmacological effects as Repaglinide.
The primary mechanism of action of Repaglinide M1-D5 is to stimulate insulin release from the pancreas. This leads to a decrease in blood glucose levels. Repaglinide M1-D5 is a fast-acting medication and is usually taken just before a meal. It is recommended to take this medication with the first bite of a meal to achieve optimal results.
The chemical structure of Repaglinide M1-D5 is similar to Repaglinide. Both medications belong to the class of drugs known as meglitinides. Repaglinide M1-D5 has a molecular weight of 426.57 g/mol and a chemical formula of C24H28N2O4S.
Repaglinide M1-D5 is primarily eliminated from the body through the kidneys. Patients with impaired renal function may require a lower dosage of Repaglinide M1-D5 to avoid adverse effects. Common side effects of this medication include hypoglycemia, weight gain, and gastrointestinal disturbances.
In conclusion, Repaglinide M1-D5 is an active metabolite of Repaglinide used to treat type 2 diabetes. It works by stimulating insulin release from the pancreas and has a fast onset of action. It is primarily eliminated through the kidneys and may cause side effects such as hypoglycemia and weight gain.
